Cargando…

Stress granule activation attenuates lipopolysaccharide-induced cardiomyocyte dysfunction

BACKGROUND: Sepsis is the leading cause of death in intensive care units. Sepsis-induced myocardial dysfunction, one of the most serious complications of sepsis, is associated with higher mortality rates. As the pathogenesis of sepsis-induced cardiomyopathy has not been fully elucidated, there is no...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yaqiao, Liu, Runmin, Wu, Kehan, Yang, Gaowei, Wang, Yusheng, Wang, Hao, Rui, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265778/
https://www.ncbi.nlm.nih.gov/pubmed/37312024
http://dx.doi.org/10.1186/s12872-023-03281-0
_version_ 1785058604160647168
author Wang, Yaqiao
Liu, Runmin
Wu, Kehan
Yang, Gaowei
Wang, Yusheng
Wang, Hao
Rui, Tao
author_facet Wang, Yaqiao
Liu, Runmin
Wu, Kehan
Yang, Gaowei
Wang, Yusheng
Wang, Hao
Rui, Tao
author_sort Wang, Yaqiao
collection PubMed
description BACKGROUND: Sepsis is the leading cause of death in intensive care units. Sepsis-induced myocardial dysfunction, one of the most serious complications of sepsis, is associated with higher mortality rates. As the pathogenesis of sepsis-induced cardiomyopathy has not been fully elucidated, there is no specific therapeutic approach. Stress granules (SG) are cytoplasmic membrane-less compartments that form in response to cellular stress and play important roles in various cell signaling pathways. The role of SG in sepsis-induced myocardial dysfunction has not been determined. Therefore, this study aimed to determine the effects of SG activation in septic cardiomyocytes (CMs). METHODS: Neonatal CMs were treated with lipopolysaccharide (LPS). SG activation was visualized by immunofluorescence staining to detect the co-localization of GTPase-activating protein SH3 domain binding protein 1 (G3BP1) and T cell-restricted intracellular antigen 1 (TIA-1). Eukaryotic translation initiation factor alpha (eIF2α) phosphorylation, an indicator of SG formation, was assessed by western blotting. Tumor necrosis factor alpha (TNF-α) production was assessed by PCR and enzyme-linked immunosorbent assays. CMs function was evaluated by intracellular cyclic adenosine monophosphate (cAMP) levels in response to dobutamine. Pharmacological inhibition (ISRIB), a G3BP1 CRISPR activation plasmid, and a G3BP1 KO plasmid were employed to modulate SG activation. The fluorescence intensity of JC-1 was used to evaluate mitochondrial membrane potential. RESULTS: LPS challenge in CMs induced SG activation and resulted in eIF2α phosphorylation, increased TNF-α production, and decreased intracellular cAMP in response to dobutamine. The pharmacological inhibition of SG (ISRIB) increased TNF-α expression and decreased intracellular cAMP levels in CMs treated with LPS. The overexpression of G3BP1 increased SG activation, attenuated the LPS-induced increase in TNF-α expression, and improved CMs contractility (as evidenced by increased intracellular cAMP). Furthermore, SG prevented LPS-induced mitochondrial membrane potential dissipation in CMs. CONCLUSION: SG formation plays a protective role in CMs function in sepsis and is a candidate therapeutic target. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12872-023-03281-0.
format Online
Article
Text
id pubmed-10265778
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102657782023-06-15 Stress granule activation attenuates lipopolysaccharide-induced cardiomyocyte dysfunction Wang, Yaqiao Liu, Runmin Wu, Kehan Yang, Gaowei Wang, Yusheng Wang, Hao Rui, Tao BMC Cardiovasc Disord Research BACKGROUND: Sepsis is the leading cause of death in intensive care units. Sepsis-induced myocardial dysfunction, one of the most serious complications of sepsis, is associated with higher mortality rates. As the pathogenesis of sepsis-induced cardiomyopathy has not been fully elucidated, there is no specific therapeutic approach. Stress granules (SG) are cytoplasmic membrane-less compartments that form in response to cellular stress and play important roles in various cell signaling pathways. The role of SG in sepsis-induced myocardial dysfunction has not been determined. Therefore, this study aimed to determine the effects of SG activation in septic cardiomyocytes (CMs). METHODS: Neonatal CMs were treated with lipopolysaccharide (LPS). SG activation was visualized by immunofluorescence staining to detect the co-localization of GTPase-activating protein SH3 domain binding protein 1 (G3BP1) and T cell-restricted intracellular antigen 1 (TIA-1). Eukaryotic translation initiation factor alpha (eIF2α) phosphorylation, an indicator of SG formation, was assessed by western blotting. Tumor necrosis factor alpha (TNF-α) production was assessed by PCR and enzyme-linked immunosorbent assays. CMs function was evaluated by intracellular cyclic adenosine monophosphate (cAMP) levels in response to dobutamine. Pharmacological inhibition (ISRIB), a G3BP1 CRISPR activation plasmid, and a G3BP1 KO plasmid were employed to modulate SG activation. The fluorescence intensity of JC-1 was used to evaluate mitochondrial membrane potential. RESULTS: LPS challenge in CMs induced SG activation and resulted in eIF2α phosphorylation, increased TNF-α production, and decreased intracellular cAMP in response to dobutamine. The pharmacological inhibition of SG (ISRIB) increased TNF-α expression and decreased intracellular cAMP levels in CMs treated with LPS. The overexpression of G3BP1 increased SG activation, attenuated the LPS-induced increase in TNF-α expression, and improved CMs contractility (as evidenced by increased intracellular cAMP). Furthermore, SG prevented LPS-induced mitochondrial membrane potential dissipation in CMs. CONCLUSION: SG formation plays a protective role in CMs function in sepsis and is a candidate therapeutic target. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12872-023-03281-0. BioMed Central 2023-05-27 /pmc/articles/PMC10265778/ /pubmed/37312024 http://dx.doi.org/10.1186/s12872-023-03281-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Yaqiao
Liu, Runmin
Wu, Kehan
Yang, Gaowei
Wang, Yusheng
Wang, Hao
Rui, Tao
Stress granule activation attenuates lipopolysaccharide-induced cardiomyocyte dysfunction
title Stress granule activation attenuates lipopolysaccharide-induced cardiomyocyte dysfunction
title_full Stress granule activation attenuates lipopolysaccharide-induced cardiomyocyte dysfunction
title_fullStr Stress granule activation attenuates lipopolysaccharide-induced cardiomyocyte dysfunction
title_full_unstemmed Stress granule activation attenuates lipopolysaccharide-induced cardiomyocyte dysfunction
title_short Stress granule activation attenuates lipopolysaccharide-induced cardiomyocyte dysfunction
title_sort stress granule activation attenuates lipopolysaccharide-induced cardiomyocyte dysfunction
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265778/
https://www.ncbi.nlm.nih.gov/pubmed/37312024
http://dx.doi.org/10.1186/s12872-023-03281-0
work_keys_str_mv AT wangyaqiao stressgranuleactivationattenuateslipopolysaccharideinducedcardiomyocytedysfunction
AT liurunmin stressgranuleactivationattenuateslipopolysaccharideinducedcardiomyocytedysfunction
AT wukehan stressgranuleactivationattenuateslipopolysaccharideinducedcardiomyocytedysfunction
AT yanggaowei stressgranuleactivationattenuateslipopolysaccharideinducedcardiomyocytedysfunction
AT wangyusheng stressgranuleactivationattenuateslipopolysaccharideinducedcardiomyocytedysfunction
AT wanghao stressgranuleactivationattenuateslipopolysaccharideinducedcardiomyocytedysfunction
AT ruitao stressgranuleactivationattenuateslipopolysaccharideinducedcardiomyocytedysfunction